Open AccessThird-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status
Author(s) -
Yuh-Min Chen,
Jen-Fu Shih,
Wen-Chien Fan,
Chieh-Hung Wu,
KunTa Chou,
Chun-Ming Tsai,
Yu-Chin Lee,
Reury-Perng Perng,
Jacqueline WhangPeng
Publication year - 2011
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1016/j.jcma.2011.03.005
Subject(s) - medicine , oncology , lung cancer , chemotherapy , performance status , line (geometry) , geometry , mathematics
Our aim here was to explore treatment efficacy of pemetrexed and docetaxel in non-small-cell lung cancer patients who had failed previous chemotherapy and epidermal growth factor receptor-tyrosine kinase inhibitor therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom